@article{article_1618895, title={Cognitive dysfunction after ischemic stroke}, journal={The European Research Journal}, volume={11}, pages={420–426}, year={2025}, DOI={10.18621/eurj.1618895}, author={Ozdogru, Derya and Erdem, Miray}, keywords={Montreal Cognitive Assessment Scale, Ischemic stroke, hyperlipidemia, cognitive impairment}, abstract={<p> <b>Objectives: </b> One of the most important and common consequences of ischemic stroke is the cognitive impairment observed after stroke. This study aimed to investigate the role of strategic stroke among post-stroke cognitive impairment using the Montreal Cognitive Assessment Scale (MOCA). </p> <p> <b>Methods: </b> This study was planned as a prospective cross-sectional study. Patients admitted between 3 and 12 months after stroke were included in the study. Patients who had a stroke at least 3 months ago, who had not been admitted for a year after the stroke, and who gave consent to participate in the study were considered as inclusion criteria. </p> <p> <b>Results: </b> This study included 45 (44.1%) females and 57 (55.9%) males. When evaluated in terms of comorbidity, the frequency of hyperlipidemia was found to be significantly higher in the cognitively impaired group (46.5% vs. 25.4%, P=0.027). Thyroid stimulating hormone (TSH) levels were found to be lower in the Cognitive Impairment Group (0.93 μIU/mL vs. 1.03 μIU/mL, P=0.021). Considering the finding rates and significance level of lesion sites between the groups, the strategic infarction rate was found to be significantly higher in the cognitively impaired group (62.8% vs. 33.9%, P=0.004). In cognitive tests, the cognitive impairment group showed significantly lower performance in all areas (P<0.05). </p> <p> <b>Conclusions: </b> It should be kept in mind that the MOCA scale can be a good evaluation scale in detecting patients with cognitive impairment after ischemic stroke. </p>}, number={2}, publisher={Prusa Medical Publishing}